|
|
| ITCA 880 / Intarcia (0 Trials) |
|
| ITCA 884 / Intarcia (0 Trials) |
|
| itepekimab (SAR440340) / Sanofi, Regeneron (0 Trials) |
|
| ITI-009 / Intra-Cellular Therapies (0 Trials) |
|
| ITI-1001 / HLB Bio Group (0 Trials) |
|
| ITI-1020 / Intra-Cellular Therapies (0 Trials) |
|
| ITI-3000 / HLB Bio Group (0 Trials) |
|
| ITI-333 / Intra-Cellular Therapies (0 Trials) |
|
| ITI-5000 / HLB Bio Group (0 Trials) |
|
| ITI-7000 / HLB Bio Group (0 Trials) |
|
| ITIL-168 / Instil Bio (0 Trials) |
|
| ITIL-306 / Instil Bio (0 Trials) |
|
| ITK-1 / Fujifilm Holdings (0 Trials) |
|
| ITM-22 / ITM Isotopen Technologien Munchen (0 Trials) |
|
| ITM-52 / ITM Isotopen Technologien Munchen (0 Trials) |
|
| ITM-91 / 3B Pharma, ITM Isotopen Technologien Munchen (0 Trials) |
|
| Itovebi (inavolisib) / Roche (0 Trials) |
|
| itraconazole / Generic mfg. (0 Trials) |
|
| itriglumide (CR-2945) / Viatris (1 Trials) |
|
| Ituxredi (rituximab biosimilar) / Dr. Reddy’s, Abbott, EMD Serono, CinnaGen, Fresenius Kabi, R-Pharm (2 Trials) |
|
| ITX 7650 / iTherX (0 Trials) |
|
| ITX-5061 / iTherX (0 Trials) |
|
| IVA-360 / Inventiva (0 Trials) |
|
| ivabradine / Generic mfg. (51 Trials) |
|
| ivabradine prolonged release / Abbott (0 Trials) |
|
| IVAC_M_uID / BioNTech (0 Trials) |
|
| IVACFLU-A/H5N1 (whole virion monovalent A/H5N1 influenza vaccine) / Institute of Vaccines and Biological Medical - IVAC (0 Trials) |
|
| IVACFLU-S (seasonal trivalent inactivated split virion influenza vaccine) / Institute of Vaccines and Biological Medical - IVAC (0 Trials) |
|
| ivaltinostat IV (CG-745) / CG Invites (3 Trials) |
|
| ivaltinostat oral (CG-750) / CG Invites (0 Trials) |
|
| ivarmacitinib (SHR0302) / Jiangsu Hengrui Pharma, Arcutis (0 Trials) |
|
| ivarmacitinib cream (ARQ-252) / Arcutis (0 Trials) |
|
| ivarmacitinib topical suspension (ARQ-255) / Arcutis (0 Trials) |
|
| Ivectosol (human grade solubilized ivermectin) / Mountain Valley (0 Trials) |
|
| Iveegam E/N (human immune globulin intravenous) / Takeda (0 Trials) |
|
| ivermectin long-acting injectable / Monash University, The Peter Doherty Institute for Infection and Immunity (0 Trials) |
|
| ivermectin extended release (LYN‐063) / Lyndra (0 Trials) |
|
| ivermectin oral / Generic mfg. (0 Trials) |
|
| ivermectin topical / Generic mfg. (4 Trials) |
|
| Ivesa (firmonertinib) / Allist, ArriVent (3 Trials) |
|
| IVheBEx (hepatitis B immunoglobulin) / AOP Orphan Pharma (0 Trials) |
|
| ivicentamab (GEN-3009) / Genmab (0 Trials) |
|
| Iviglob Ex (extra purified normal human IV immunoglobulin) / VHB Life Sci (0 Trials) |
|
| IVL5003 / Inventage Lab, Prazer Therap (0 Trials) |
|
| Ivlizi (divozilimab) / Biocad (0 Trials) |
|
| ivospemin (SBP-101) / Panbela Therap (0 Trials) |
|
| IVS-3001 / Invectys (0 Trials) |
|
| IVS-4001 / Invectys (0 Trials) |
|
| IVS-5001 / Invectys (0 Trials) |
|
| IVT PCV-25 / Inventprise (0 Trials) |
|
| IVT-8086 / Innova Therap (0 Trials) |
|
| ivuxolimab (PF-04518600) / Pfizer (7 Trials) |
|
| IVX-121 / AstraZeneca (0 Trials) |
|
| IVX-411 / AstraZeneca (0 Trials) |
|
| IVX-A12 / AstraZeneca (0 Trials) |
|
| IVX-SKIN / Invion (0 Trials) |
|
| IVX037 / ImmVirx (0 Trials) |
|
| IW-3300 / Ironwood Pharma (0 Trials) |
|
| IW-6118 / Ironwood Pharma (0 Trials) |
|
| IXC-103 / Ixchel Pharma (0 Trials) |
|
| IXC-109 / Ixchel Pharma (0 Trials) |
|
| IxCell hUC-MSC-S / IxCell Biotech (0 Trials) |
|
| Ixchiq (VLA1553) / Valneva (0 Trials) |
|
| Ixempra (ixabepilone) / Otsuka, R-Pharm (5 Trials) |
|
| Ixiaro (IC51) / Valneva (7 Trials) |
|
| Ixifi (infliximab-qbtx) / Pfizer, Sandoz (2 Trials) |
|
| Ixinity (trenonacog alfa) / Medexus (4 Trials) |
|
| ixmyelocel-t (ixCELL-DCM) / Vericel (1 Trials) |
|
| ixoberogene soroparvovec (ADVM-022) / Adverum Biotech (0 Trials) |
|
| izalontamab (SI-B001) / Biokin Pharma (0 Trials) |
|
| izalontamab brengitecan (BL-B01D1) / Biokin Pharma, BMS (0 Trials) |
|
| izastobart (HIB210) / Biogen (0 Trials) |
|
| Izcargo (pabinafusp alfa) / JCR Pharma (0 Trials) |
|
| izeltabart tapatansine (IMGC936) / MacroGenics, AbbVie (0 Trials) |
|
| izencitinib (TD-1473) / Theravance Biopharma (2 Trials) |
|
| Izervay (avacincaptad pegol intravitreal solution) / Astellas (4 Trials) |
|
| izokibep (ABY-035) / ACELYRIN (0 Trials) |
|
| izorlisib (MEN1611) / Menarini (1 Trials) |
|
| izuforant (JW1601) / JW Pharma (0 Trials) |
|
| izumerogant (IMU-935) / Immunic (0 Trials) |
|
| izuralimab (XmAb23104) / Xencor (0 Trials) |
|
|